Case Report: Recurrent coronary in-stent restenosis as the primary manifestation of non-criteria antiphospholipid syndrome confirmed by anti-phosphatidylserine/prothrombin IgM antibodies. [PDF]
Tuo M, Li Y, Shi Z, Ma M, Feng Y, Yu J.
europepmc +1 more source
Prevention of In-Stent Restenosis After PCI by Saponin Natural Products: Inhibition of Platelet Activation. [PDF]
Lei X +5 more
europepmc +1 more source
Carotid Endarterectomy With Stent Explantation for In-Stent Restenosis in Two Patients and Review of the Literature. [PDF]
Alchaer MW +3 more
europepmc +1 more source
Recurrent coronary artery in-stent restenosis caused by metal allergy: a case report. [PDF]
Li Y +5 more
europepmc +1 more source
Clinical efficacy of drug-eluting stents in the treatment of vertebral artery stenosis and analysis of factors contributing to stent restenosis. [PDF]
Wei X +9 more
europepmc +1 more source
The Prognostic Value of Different Patterns of Neoatherosclerosis and Treatment Modality in Patients With Coronary In-Stent Restenosis. [PDF]
Shen Y +9 more
europepmc +1 more source
Inflammatory Prognostic Index: A Novel Predictor of In-Stent Restenosis Following Drug-Eluting Stent-Percutaneous Coronary Intervention. [PDF]
Turgul C, Kelesoglu S.
europepmc +1 more source
Association between antiphospholipid antibodies, rheumatic-immune inflammation, and coronary in-stent restenosis. [PDF]
Mao W +6 more
europepmc +1 more source
Retrospective Analysis of In-Stent Restenosis in Diabetic Patients. [PDF]
Khalid H +6 more
europepmc +1 more source
Construction and validation of a prediction model for in-stent restenosis following coronary stent implantation during dual antiplatelet therapy. [PDF]
Zhang Z, Huang Y, Ye Y, Wang Z.
europepmc +1 more source

